IPSC compared with ZLAB: revenue, margins and what each company keeps, and the suppliers and customers both name

IPSCCentury Therapeutics, Inc.

Mkt capRevenueRevenue

ZLABZai Lab Ltd

Mkt capRevenueRevenue

Compare

IPSCCentury Therapeutics, Inc.

ZLABZai Lab Ltd

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

IPSC1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±29.8%▼−4.85%×0.16

ZLAB

Reportimpliedrealized× implied

Q2 FY26—▲+13.66%—

May 7 '26—▼−5.93%—

Q1 FY26

= impliedIPSC realized, solidZLAB realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

—

▲+1.55%

—

Nov 6 '25—▼−6.65%—

IPSCCentury Therapeutics, Inc.

1.49▲+1.76%· post 1.48

Mkt cap$266.2MRevenue$109MQ1 FY25Revenue$7MFY24

ZLABZai Lab Ltd

22.09▼−1.21%· post 22.10

ClosedOct 30 '26

Mkt cap$2.5BRevenue$106MQ2 FY26Revenue$460MFY25

Compare

ClosedOct 30 '26

IPSCCentury Therapeutics, Inc.

ZLABZai Lab Ltd

1.49▲+1.76%post 1.48

Price

22.09▼−1.21%post 22.10

$266.2M

Mkt cap

$2.5B

Q1 FY25$109M

Revenue

$106MQ2 FY26

FY24$7M

Revenue

$460MFY25

IPSC1.49▲+1.76%vsZLAB22.09▼−1.21%ClosedOct 30 '26